 PHILADELPHIA, Jan. 03, 2022 GLOBE NEWSWIRE -- Passage Bio, Inc. Nasdaq: PASG, a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system CNS disorders, today announced that Bruce Goldsmith, Ph.D., president, and chief executive officer, will present at the 40th Annual J.P. Morgan Healthcare Conference being held virtually on Monday, January 10, 2022 at 10:30 a.m. ET. 